Dhanvantri Jeevan Rekha Ltd.
Snapshot View

13.00 -0.47 ▼-3.5%

09 February 2023, 02:27:00 PM
Volume: 266

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Compare with Industry peers
Website http://www.djrl.org.in
Market Cap 5.33 Cr.
Enterprise Value(EV) 5.52 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) -0.44 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2022-09
Industry PE 46.98 Trailing Twelve Months Ending 2022-09
Book Value / Share 22.57 Trailing Twelve Months Ending 2022-09
Price to Book Value 0.58 Calculated using Price: 13.00
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 0.41 Cr. 4,098,400 Shares
FaceValue 10
Company Profile
Dhanvantri Jeevan Rekha, incorporated on June 11, 1993 is a multi speciality hospital providing reliable diagnostic and therapeutical services. We lay great emphasis on providing good nursing care and clean environment. Dhanvantri hospital has been on the fore front of providing state of art equipment and services in western UP since 1994.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-3.49%
1 Week
-8.26%
1 Month
-6.88%
3 Month
-16.40%
6 Month
-3.70%
1 Year
-28.96%
2 Year
+54.76%
5 Year
-62.26%
10 Year
+151.94%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 8.79 14.25 10.75 5.68 7.10 0.44 -2.51 -14.69 5.31
Return on Capital Employed (%) 14.04 21.14 16.71 11.79 7.91 1.97 -2.55 -16.37 7.40
Return on Assets (%) 6.83 10.82 7.95 3.77 4.46 0.30 -1.76 -10.03 3.51

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 7 8 9 10 11 11 10 9 10 9
Non Curr. Liab. 0 1 1 2 3 1 1 2 2 2
Curr. Liab. 2 2 2 4 3 3 3 3 2 3
Minority Int.
Equity & Liab. 8 11 13 16 16 15 15 14 14 14
Non Curr. Assets 5 7 8 13 13 13 12 11 11 10
Curr. Assets 3 4 4 3 3 3 3 2 4 4
Misc. Exp. not W/O
Total Assets 8 11 13 16 16 15 15 14 14 14

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 7 8 9 11 14 17 18 10 17 17
Other Income 0 0 0 0 0 0 0 0 0 0
Total Income 8 8 10 12 14 17 18 10 17 17
Total Expenditure -6 -6 -8 -10 -12 -16 -18 -11 -15 -16
PBIDT 2 2 2 2 2 1 1 -1 2 1
Interest 0 0 0 0 0 0 0 0 0
Depreciation -1 0 0 0 -1 -1 -1 -1 -1 -1
Taxation 0 0 0 0 0 0 0 0 0 0
Exceptional Items
PAT 1 1 1 1 1 0 0 -1 0 0
Adjusted EPS 1 3 2 1 2 0 -1 -3 1 0

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 1 1 1 1 4 1 1 1 0 1
Cash Fr. Inv. 0 -1 -1 -1 -4 -1 0 0 0
Cash Fr. Finan. 0 0 0 1 0 -2 0 0 0
Net Change 0 0 0 0 0 0 -1 1 0 1
Cash & Cash Eqvt 1 0 0 1 1 1 0 1 1 2

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 19.77 19.77 19.77 19.77 19.77 19.77 19.77 19.77 19.77
Public 80.23 80.23 80.23 80.23 80.23 80.23 80.23 80.23 80.23
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Mon, 06 Feb 2023
Board Meeting Intimation for Sub: Intimation Of Board Meeting
DHANVANTRI JEEVAN REKHA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2023 inter alia to consider and approve Dear Sir Pursuant to the Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations) this is to inform you that a Meeting of the Board of Directors of the Company will be held on Tuesday the 14th February 2023 at 11:30 AM to inter alia consider and approve the unaudited financial results along with the Limited Review Report of the Auditors for the quarter ended on 31st December 2022 and To consider appointment of Independent Director Further pursuant to the Companys revised Code of Internal Procedure and Conduct for Regulating Monitoring and Reporting of Trading by Insiders framed under SEBI (Prevention of Insider Trading) Regulation 2015 the trading window for dealing in the equity shares of the Company has already been closed from January1 2023 to the conclusion of 48 hours after the results are made public.
Mon, 06 Feb 2023
Update on board meeting
DHANVANTRI JEEVAN REKHA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2023 inter alia to consider and approve Sub: Intimation of Board MeetingDear Sir Pursuant to the Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations) this is to inform you that a Meeting of the Board of Directors of the Company will be held on Tuesday the 14th February 2023 at 11:30 AM to inter alia consider and approve the unaudited financial results along with the Limited Review Report of the Auditors for the quarter ended on 31st December 2022.Further pursuant to the Companys revised Code of Internal Procedure and Conduct for Regulating Monitoring and Reporting of Trading by Insiders framed under SEBI (Prevention of Insider Trading) Regulation 2015 the trading window for dealing in the equity shares of the Company has already been closed from January1 2023 to the conclusion of 48 hours after the results are made public.
Tue, 10 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Dear Sir/ Maam Pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulation 201 please find the enclosed herewith copy of the certificate dated 05th January 2023 received from M/s Beetal Financial& Computer services (P) Ltd. the Registrar and Share Transfer Agent of the Company for the Quarter ended 31st December 2022

Technical Scans View Details >>

Wed, 08 Feb 2023
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Opening at High Opening at High
Opening at Low Opening at Low

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 243,148.61 1,009.25 -0.4%
Cipla Ltd. 83,886.47 1,023.50 -1.5%
Dr. Reddy's Laboratories Ltd. 74,707.50 4,490.35 +0.1%
Divi's Laboratories Ltd. 74,340.49 2,817.05 +0.6%
Apollo Hospitals Enterprise Ltd. 63,077.61 4,398.00 +0.2%
Torrent Pharmaceuticals Ltd. 52,675.65 1,540.00 -1.1%
Zydus Lifesciences Ltd. 47,993.66 474.60 +0.1%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 57.66 1,009.25 -0.4%
Cipla Ltd. Consolidated 2022-12 31.80 1,023.50 -1.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 20.50 4,490.35 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-12 31.01 2,817.05 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 75.13 4,398.00 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 63.19 1,540.00 -1.1%
Zydus Lifesciences Ltd. Consolidated 2022-12 23.29 474.60 +0.1%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.39 1,009.25 -0.4%
Cipla Ltd. Consolidated 2022-12 3.70 1,023.50 -1.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.39 4,490.35 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-12 5.98 2,817.05 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.54 4,398.00 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.24 1,540.00 -1.1%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.78 474.60 +0.1%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,009.25 -0.4%
Cipla Ltd. Consolidated 2022-03 0.04 1,023.50 -1.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,490.35 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,817.05 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,398.00 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,540.00 -1.1%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 474.60 +0.1%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,009.25 -0.4%
Cipla Ltd. Consolidated 2022-03 13.10 1,023.50 -1.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,490.35 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,817.05 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,398.00 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,540.00 -1.1%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 474.60 +0.1%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,009.25 -0.4%
Cipla Ltd. Consolidated 2022-03 13.10 1,023.50 -1.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,490.35 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,817.05 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,398.00 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,540.00 -1.1%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 474.60 +0.1%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,009.25 -0.4%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,023.50 -1.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,490.35 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,817.05 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,398.00 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,540.00 -1.1%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 474.60 +0.1%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,009.25 -0.4%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,023.50 -1.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,490.35 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,817.05 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,398.00 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,540.00 -1.1%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 474.60 +0.1%

FAQ's On Dhanvantri Jeevan Rekha Ltd.

What is DhanvantriJeevan Rek share price?

Can I buy DhanvantriJeevan Rek shares now?

What is the Market Cap of DhanvantriJeevan Rek?

What are the key metrics to analyse DhanvantriJeevan Rek?

What is the 52 Week High and Low of DhanvantriJeevan Rek?

What is the trend of DhanvantriJeevan Rek share price?